Understanding the Ryan White HIV/AIDS Program

June 4, 2013

Logistics

This is intended to be a safe discussion space for funders! If you wear different hats at your organization, please bring your grantmaking one to the Q&A.

The operator will provide instructions and open lines for discussion at Q&A.

In the interim, you can send questions via the chat function at your right, via email sarah@fcaaids.org, or via Twitter @FCAA.

We will pause for clarification questions only after our first presenter, and then open Q&A after the remaining presenters.

The call will be recorded and available on www.fcaaids.org after the call.

Agenda

Welcome & Logistics John Barnes, FCAA

Ryan White & the Affordable Care Act Dr. Laura Cheever, Acting Associate Administrator,

Department of Health & Human ServicesHealth Resources & Services Administration HIV/AIDS Bureau

Updating the Ryan White Program for a New Era: Key Issues & Questions for the Future Jen Kates, Vice President & Director of Global Health & HIV Policy,

Kaiser Family Foundation Jeffrey Crowley, Program Director, National HIV/AIDS Initiative,

O’Neill Institute, Georgetown Law

Moderated Q&A

Closing

Ryan White Program and Affordable Care AcT

for Funders Concerned About AIDSJune 4, 2013

Laura W. Cheever, MD

Acting Associate AdministratorDepartment of Health and Human ServicesHealth Resources and Services AdministrationHIV/AIDS Bureau

Key Provisions of Ryan White

• Payer of last resort• Can “wrap around” other insurance

• 75% core services/ 25% support services• Core: outpt care, labs, meds, case management, mental health

tx, substance abuse tx, oral health• Support: transportation, emergency housing, child care, food

assistance• Can apply for Waiver if: no ADAP waiting list and core services

available to all eligible patients

• Funding based on living HIV/AIDS cases in the most recent year of data

5

FY 2012 Ryan White HIV/AIDS Program Enacted Appropriation, $2.39* Billion

*“Includes $25 million for SPNS funding from Evaluation Set-Aside; $50 million announced on World AIDS Day 2011Source: HAB/HRSA Budget Office

6

Ryan White HIV/AIDS Program Appropriations History 1991-2012

Ryan White HIV/AIDS Program - Clients Served

• Serves over 529,000 uninsured and underinsured persons affected by HIV/AIDS annually

• Approximately 208,809 people received medications through ADAP in 2010• About 46% of those on ARVs in U.S. use ADAP services

• Reaches those most in need, with an estimated 72% racial minorities, 31% women, and 81.6% uninsured/underinsured or receiving public health benefits (Source: RW Data Report, 2010)

• CDC reported AIDS cases- 66.5% minority, 23.5% women

• Reduced disparities in HIV care and treatment outcomes attributed to RW program (Saag, CID, 2012)

8

RW Clients’ Insurance Status

25.5

28.79.3

7.8

12.7

12.2

Insurance StatusNoInsuranceMedicaid

Medicare

Other Public

Private

MultipleInsurance

• 25.5% of RW clients are uninsured

• Remainder are underinsured, with RW wrapping around to provide a full compliment of services (care completion)

9

Missing/unknown values (18%) excluded. Source: 2010 RW Services Report- Preliminary data

RW Clients’ Income • Most RW clients are below 100% FPL

• Data is not available for clients <133% FPL

10

Missing/unknown values (20%) excluded.Source: 2010 RW Services Report- Preliminary Data

Lessons Learned from States with Expanded Coverage

• California• Continuity of care with expert, trusted providers• Gaps in care

• Massachusetts• Utilize RW funds to support services to address

gaps in treatment cascade (care completion)• Newly diagnosed and reported HIV rate fell 25%

between 2006 & 2009 (increased 2% in U.S.); most recent rate fell by >50%

11

• Medicaid expansion to 133% of FPL• Subsidies via health insurance exchanges 133% - 400% FPL

• Private market reforms• Ban on health insurance rescissions• Elimination of lifetime and annual caps

• Support of the medical home

Affordable Care Act Provisions with Future Impact on Ryan White

12

Ryan White and ACA: Areas of Interaction

•Funding based on HIV/AIDS cases• Aligns with the epidemic• Not based on unmet need

•Payer of last resort• Little flexibility• Continuity of care

•75% / 25% core/support services

13

The Future of Ryan White

• Full implementation of the ACA does not eliminate the need for the Ryan White Program

• Gaps in coverage will remain – both Medicaid and private insurance• Gaps in services: oral health care, medications,

support services to link clients to care• Some groups will remain uninsured

• Training of providers (AETC)

14

Status of the Ryan White Program• The Ryan White HIV/AIDS Program is currently

authorized through September 30, 2013.

• After that date, the Program will not sunset and can continue to operate through Congressional appropriations with or without subsequent legislation.

• The decision of whether or not to pursue reauthorization of the Ryan White Program will lie with Congress.

Support for the Ryan White Program • The Administration strongly supports the Ryan White HIV/AIDS Program (RWHAP) and the continuation of the services provided.

• The Administration recognizes the need to continue the RWHAP, even as full implementation of the Affordable Care Act moves forward. • Critical role in improving outcomes along the

Continuum of Care/ Treatment Cascade

Number and Percentage of HIV-infected Persons Engaged in Selected Stages of the Continuum of HIV care—United States

Ryan White-funded Medical CareRyan White Services Report 2010 (preliminary)

Doshi RK et al. CROI 2013, abstract 1031a.

56%

79%

Retention in Medical CareRyan White Services Report 2010 (preliminary)

Retained in medical care:At least 2 medical visits that were at least 90 days apart

Doshi RK et al. CROI 2013, abstract 1031a

Antiretroviral TherapyRyan White Services Report 2010 (preliminary)

Prescribed ART:Received a prescription for ART at any time in the year

Doshi RK et al. CROI 2013, abstract 1031a.

80%

Viral Load SuppressionRyan White Services Report 2010 (preliminary)

Viral load suppressed:HIV-1 RNA <200 copies/ml at the most recent check

Doshi RK et al. CROI 2013, abstract 1031a.

70%

Contact Information

Laura Cheever, MD

Acting Associate Administrator

Department of Health and Human Services

Health Resources and Services Administration

HIV/AIDS Bureau

301-443-1993

lcheever@hrsa.gov

Ryan White HIV Care ContinuumDefinitions

Doshi RK et al. CROI 2013, abstract 1031a.

Updating The Ryan White Program for a New Era:Key Issues and Questions for the FuturePresentation for the FCAA & Grantmakers in Health Webinar on the Landscape of HIV Care in the United StatesJune 4, 2013

Jen Kates, Kaiser Family FoundationJeffrey S. Crowley, O’Neill Institute, Georgetown Law

Leading role

Overview

Major role, but not leading

100%

82%

Our Nation can be proud of its legacy of responding to the care and treatment needs of people living with HIV: •The Ryan White HIV/AIDS Program is a critical contributor to our past and current successes •It is likely to remain critically necessary to the HIV response•The context in which Ryan White operates is changing, and this create new opportunities•We need both short-term strategies to support people with HIV through the immediate ACA transition and a long-term vision of how Ryan White fits into a more integrated and efficient health care system

Leading role

“Updating the Ryan White HIV/AIDS Program for a New Era”

Major role, but not leading

100%

82%

• First authorized in 1990– Pre-treatment era– Pre-routine HIV screening era– Pre-TasP

• Is critical part of HIV care delivery system in U.S.

• Largest HIV-specific federal grant program in U.S.

• Third largest source of federal funding for HIV care

• Funding risen over time, though not necessarily kept pace with need

Ryan White is the Third Largest Source of Federal Funding for HIV Care in the U.S.

SOURCE: Kaiser Family Foundation analysis of data from OMB, CBJs, and appropriations bills.

NOTES: The Consumer Price Index (CPI) from the Bureau of Labor Statistics (BLS) was used to adjust for inflation. HIV prevalence data are estimates based on analysis of data from CDC. SOURCES: Funding amounts based on Kaiser Family Foundation analysis of data from OMB, CBJs, appropriations bills, and CRS; Prevalence based on data from CDC; U.S. Department of Labor, Bureau of Labor Statistics.

Federal Ryan White Funding (adjusted for inflation) and HIV Prevalence, 1991-2012

Leading role

Brief Reauthorization History

Major role, but not leading

100%

82%

• Reauthorized four times– 1996– 2000– 2006– 2009

• Current authorization expires September 30, 2013 – No sunset provision– Programs can continue without an

authorization– An authorization does not guarantee

appropriations• Timing of next reauthorization

uncertain

A New Context

The “HIV Treatment Cascade” in the U.S.

2/3 not in regular care

Only 33% on ART

Only 25% virally suppressed

SOURCE: Adapted from CDC "HIV in the United States–The Stages of Care" July 2012.

NOTES: Based on those with reported insurance status (duplicated number of clients, N=764,163) in 2010.SOURCE: HRSA, HAB, http://hab.hrsa.gov/stateprofiles/index.htm.

Most Ryan White Clients Are Insured, And Rely on the Program Because They Face Limits in Their Coverage

Leading role

Massachusetts Example

Major role, but not leading

100%

82%

• Began implementing health reform more than a decade ago, to near universal access

• Changed how Ryan White funding was used in state, with greater share of resources shifting from paying for care to paying for:– Insurance continuation– Co-payments– Support services to help engage people with HIV in care and

support adherence• State has observed decline in new HIV diagnoses, high

viral load suppression• Attributes to the combination of expanded insurance

coverage, ART access, and extensive HIV community care network including Ryan White providers

SOURCES: Cranston K et al. (2012). “Controlling the Massachusetts HIV Epidemic: Triangulated Measures of Care Access and HIV Incidence”,19th International AIDS Conference: Abstract no. TUPE212; Kevin Cranston, Personal communication, January 22, 2013.

Key Issues & Questions

Leading role

Four Key Areas of Consideration

Major role, but not leading

100%

82%

1. Supporting People with HIV at Each Stage of the Treatment Cascade, from Diagnosis to Viral Suppression

2. Building HIV Care Networks in Underserved Communities

3. Integrating HIV Care Expertise into the Mainstream Health Care System

4. Effectively and Fairly Allocating Ryan White Resources

Leading role

Supporting People with HIV at Each Stage of the Treatment Cascade

Major role, but not leading

100%

82%

• Focus on supporting the maximum number of people along the treatment cascade

• Streamline and strengthen jurisdictional planning

• Integrate HIV prevention and care planning• Measure HIV clinical indicators and performance

along the cascade• Update the 75/25 rule

SOURCES: Adapted from CDC "HIV in the United States–The Stages of Care" July 2012; Service Definitions from HRSA, HAB, 2012 Annual Ryan White HIV/AIDS Program Services Report (Rsr) Instruction Manual.

Select Examples of Ryan White Services That Support Clients Along The HIV Treatment Cascade

Treatment Adherence

Health Insurance Premium Assistance & Cost-Sharing

Leading role

Building HIV Care Networks in Underserved Communities

Major role, but not leading

100%

82%

• Re-tool Ryan White to better reach the most marginalized populations

• Strengthen the Ryan White program’s focus on gay and bisexual men

• Consider new programs for high cost cases or especially vulnerable populations

• Integrate people living with HIV and affected communities into care networks to provide testing, linkage, and retention services

• Support CBO planning for re-tooling, coordination and consolidation

Leading role

Integrating HIV Care Expertise into the Mainstream Health Care System

Major role, but not leading

100%

82%

• Address payer of last resort limitation during coverage transitions

• Enhance Ryan White’s ability to help individuals navigate insurance transitions

• Consider new service models to remove barriers to continuous care

• Work with other parts of the health system to strengthen the quality of HIV care

• Strengthen collaboration and coordination between Ryan White medical and support services providers

• Support HIV providers and the HIV workforce

Leading role

Effectively and Fairly Allocating Ryan White Resources

Major role, but not leading

100%

82%

• Reconsider funding formulas and allocation mechanisms

• Allocate funding to Parts A and B for both services and other program functions

• Expand or modify the SPNS program to encourage investigator-driven innovation

• Simplify grantee application and reporting procedures

Looking Forward

• Insurance coverage alone ≠ access to or receipt of care

• Ryan White is nation’s safety net for people with HIV and will continue to need to fill the gaps in care for PLWHA – Who face limits in their coverage– Have no coverage

• Will need to change, but continue to be critical; in unique position to help improve performance along treatment cascade

• Impact will depend on state decisions on Medicaid expansion and health care marketplaces, future support in Congress

Key Messages

• All of the issues require further policy developmentEach topic requires more in-depth analysis and discussion among stakeholders to develop actual legislative or administrative proposals

• Next couple of years can be used to bring innovative ideas to the tableRyan White medical and non-medical providers will be adapting to new insurance programs and they may be exposed to new models of service delivery. The ACA implementation experience could lead to new approaches for bolstering aspects of Ryan White.

• ACA and the treatment cascade may create more openness to changeThe current HIV policy dialogue is not focused on protecting the status quo,

but rather, how to improve performance on the cascade and how to navigate the ACA transition. This may make it easier for stakeholders to considers updates to Ryan White than during past reauthorizations.

What is Needed to Build on Our Paper?

• Articulate a vision and develop a planIn considering the National HIV/AIDS Strategy, the treatment cascade, and changes in the health system, more work is needed to support the community in defining a vision for the future and planning how to achieve it

• Help providers and stakeholders adaptRyan White is a treasured resource with history and expertise that must be retained. In navigating changes in the health system, we need to support providers and others in gaining new skills and taking on new roles

• Support community dialogueChange is difficult. More dialogue is needed at federal, state, and local levels to maximize consensus

• Generate analysis and educate policymakersMore work is needed to educate policymakers and community members about what science tells us about best practices and interventions and to support research to answer critical questions

How Can Philanthropy Contribute to a Strengthened HIV Care System?

• We are poised to make major progress at getting more Americans with HIV better supported in systems of care in ways that lead to much better population-level viral suppression.

• For the foreseeable future, the Ryan White HIV/AIDS Program is likely to have a central role in seizing these opportunities and moving us closer to ending the HIV epidemic in the United States.

• We have a time-limited window in which philanthropy can help the HIV community to navigate through fundamental reforms in health care delivery in ways that leave the Ryan White HIV/AIDS Program stronger and more widely supported than ever.

Conclusion

Q&A

SAVE THE DATES!

FCAA’s next program committee call:June 12th at 1 pm ETEmail sarah@fcaaids.org for more info

Part 2 webinar: Social Innovation FundJuly TBD

FCAA’s 2013 AIDS Philanthropy SummitDecember 9 & 10, DC

Thank you!

Visit http://www.fcaaids.org/RyanWhite for resources and a recording of today’s call

Visit http://www.gih.org to learn more about the Grantmakers in Health

Remaining questions? Share them with us by email sarah@fcaaids.org or via Twitter @FCAA